RECRUITING

Preventing Childbirth-Related PTSD With Expressive Writing

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to test a brief psychological intervention given to individuals in the first days following childbirth who have experienced a potentially stressful childbirth. The treatment is aimed at preventing post-traumatic stress disorder following childbirth and promoting maternal-infant bonding. In the days following childbirth, participants will be asked to write about their childbirth experience or a neutral event for three consecutive days, for around 15 minutes each day. Additionally, they will complete a short survey before and after the intervention about their birth experience and mental health. Around 2 months postpartum (with the option of up to around Month 3 PP), participants will take part in mental health and physiological assessments, and in a brief play session with their infant.

Official Title

The Effects of Expressive Writing Following Traumatic Childbirth

Quick Facts

Study Start:2023-11-08
Study Completion:2026-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05662423

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 50 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women who recently delivered at Massachusetts General Hospital (MGH).
  2. * Women who are at risk for developing CB-PTSD based on their scoring of \>16 on the Peritraumatic Distress Inventory (PDI).
  1. * Age \<18 or \>50.
  2. * Stillbirth.
  3. * Down's Syndrome, other serious genetic disorder in the newborn, or serious birth defect (e.g., microcephaly, spina bifida).
  4. * Admission to the neonatal intensive care unit (NICU) for more than 1 week or infant that is not medically healthy.
  5. * Current diagnosable DSM-5 psychotic or bipolar disorder, or current substance abuse disorder.
  6. * Active suicidality (assessed case by case).
  7. * Present substance abuse as indicated in medical records.
  8. * Severe maternal morbidity (assessed case by case).
  9. * General anesthesia.
  10. * Inability to understand the study procedures, risks, and side effects, or to otherwise give informed consent for participation due to neurological or other reasons.
  11. * Inability to understand English.

Contacts and Locations

Study Contact

Sharon Dekel, Ph.D. M.Phil., M.S.
CONTACT
617-726-1352
sdekel@mgh.harvard.edu

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02129
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-08
Study Completion Date2026-01-31

Study Record Updates

Study Start Date2023-11-08
Study Completion Date2026-01-31

Terms related to this study

Keywords Provided by Researchers

  • Mother-Infant Bonding
  • Postpartum Depression
  • Postpartum PTSD
  • Expressive Writing

Additional Relevant MeSH Terms

  • PTSD (Childbirth-Related)